Current and Emerging Targets in Immunotherapy for Osteosarcoma

Osteosarcoma is the most common primary malignancy of bone. Although outcomes of patients with osteosarcoma have improved since the introduction of chemotherapy, outcomes of metastatic or unresectable osteosarcomas are still unsatisfactory. To improve osteosarcoma outcomes, the development of novel...

Descripción completa

Detalles Bibliográficos
Autores principales: Miwa, Shinji, Shirai, Toshiharu, Yamamoto, Norio, Hayashi, Katsuhiro, Takeuchi, Akihiko, Igarashi, Kentaro, Tsuchiya, Hiroyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6332920/
https://www.ncbi.nlm.nih.gov/pubmed/30693030
http://dx.doi.org/10.1155/2019/7035045

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6332920/
https://www.ncbi.nlm.nih.gov/pubmed/30693030
http://dx.doi.org/10.1155/2019/7035045

Ejemplares similares